Stephen Brannan

Company: Karuna Therapeutics

Job title: Former Chief Medical Officer

Seminars:

The Potential of the Muscarinic System: Highlighting the Journey of KarXT Through Phase 1-3 3:20 pm

Evaluating the landscape of muscarinics in development for schizophrenia Explaining how the combination KarXT minimizes off-target muscarinic side effects in the clinic Outlining the factors that contributed to the strong results of the late phase trialsRead more

day: Conference Day 1 PM